Preventing recurrent acute diverticulitis with pharmacological therapies
- PMID: 24179670
- PMCID: PMC3807763
- DOI: 10.1177/2040622313498809
Preventing recurrent acute diverticulitis with pharmacological therapies
Abstract
Acute diverticulitis of the colon represents a significant burden for national health systems, in terms of direct and indirect costs. Past guidelines claimed that recurrent episodes (two or more) of diverticulitis need surgery, but revised guidelines recommend an individualized approach to patients after an attack of acute diverticulitis. For these reasons, conservative treatment has become the preferred choice after an episode of diverticulitis. Thus, significant efforts are now being focused to identify the correct therapeutic approach to prevent diverticulitis relapses. Nonabsorbable antibiotics, 5-aminosalicylic acid and probiotics are currently being investigated in this way. The effectiveness and the future perspectives of these treatments are discussed herein.
Keywords: 5-aminosalicylic acid; acute diverticulitis; high-fiber diet; nonabsorbable antibiotics; probiotics; recurrence.
Conflict of interest statement
Figures
Similar articles
-
Recent advances in the treatment of colonic diverticular disease and prevention of acute diverticulitis.Ann Gastroenterol. 2016 Jan-Mar;29(1):24-32. Ann Gastroenterol. 2016. PMID: 26752946 Free PMC article. Review.
-
Management of diverticulosis: what's new?Minerva Med. 2017 Oct;108(5):448-463. doi: 10.23736/S0026-4806.17.05201-6. Epub 2017 May 2. Minerva Med. 2017. PMID: 28466633 Review.
-
Efficacy, safety, and applicability of outpatient treatment for diverticulitis.Drug Healthc Patient Saf. 2014 Mar 31;6:29-36. doi: 10.2147/DHPS.S61277. eCollection 2014. Drug Healthc Patient Saf. 2014. PMID: 24729730 Free PMC article. Review.
-
Diverticulosis today.Minerva Gastroenterol Dietol. 2019 Mar;65(1):42-52. doi: 10.23736/S1121-421X.18.02525-4. Epub 2018 Oct 2. Minerva Gastroenterol Dietol. 2019. PMID: 30293416 Review.
-
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.Aliment Pharmacol Ther. 2015 Sep;42(6):664-84. doi: 10.1111/apt.13322. Epub 2015 Jul 22. Aliment Pharmacol Ther. 2015. PMID: 26202723 Review.
Cited by
-
Resolution of multiply recurrent and multifocal diverticulitis after fecal microbiota transplantation.Tech Coloproctol. 2020 Sep;24(9):971-975. doi: 10.1007/s10151-020-02275-w. Epub 2020 Jun 29. Tech Coloproctol. 2020. PMID: 32601752
-
Risk factors and incidence of 90-day readmission for diverticulitis after an acute diverticulitis index admission.Int J Colorectal Dis. 2021 Feb;36(2):347-352. doi: 10.1007/s00384-020-03769-7. Epub 2020 Oct 6. Int J Colorectal Dis. 2021. PMID: 33025103
-
Factors Associated with Repeated Health Resource Utilization in Patients with Diverticulitis.J Gastrointest Surg. 2017 Jan;21(1):112-120. doi: 10.1007/s11605-016-3245-5. Epub 2016 Sep 9. J Gastrointest Surg. 2017. PMID: 27613732
-
Diverticulitis in Morbidly Obese Adults: A Rise in Hospitalizations with Worse Outcomes According to National US Data.Dig Dis Sci. 2020 Sep;65(9):2644-2653. doi: 10.1007/s10620-019-06002-w. Epub 2020 Jan 3. Dig Dis Sci. 2020. PMID: 31900720
References
-
- Batra A., Siegmund B. (2012) The role of visceral fat. Dig Dis 30: 70–74 - PubMed
-
- Bargellini T., Martellucci J., Tonelli P., Valeri A. (2013) Long-term results of treatment of acute diverticulitis: still lessons to be learned? Updates Surg 65: 125–130 - PubMed
-
- Bassotti G., Villanacci V. (2012) Colonic diverticular disease: abnormalities of neuromuscular function. Dig Dis 30: 24–28 - PubMed
-
- Bianchi M., Festa V., Moretti A., Ciaco A., Mangone M., Tornatore V., et al. (2011) Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment Pharmacol Ther 33: 902–910 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous